Base Year
Historical Year
Forecast Year
The global cancer supportive care drugs market size attained a value of USD 21.18 billion in 2023, driven by rising demand for supportive care drugs, increased biosimilar uptake, increased expenditure on the healthcare sector, and the rising accessibility to efficient therapeutic techniques, are expected to aid the market growth. The market is anticipated to grow at a CAGR of 2.3% during the forecast period of 2024-2032 to attain a value of USD 25.99 billion by 2032.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
It is estimated that the global cancer burden has risen to 18.1 million new cases and 9.6 million deaths in 2018. The most prominent kinds of cancer with the greatest demand for supportive care drugs are lung and breast cancer.
The global cancer supportive care drugs market can be broadly categorised on the basis of its drug class into:
Market Breakup by Drug Type
Market Breakup by Cancer Type
Market Breakup by Distribution Channel
Market Breakup by Region
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
It is anticipated that increased biosimilar uptake, a large number of side effects connected with cancer treatment, increased expenditure on the healthcare sector, and the accessibility to the efficient therapeutic techniques, including target-specific and tailored treatments, are driving the global cancer supportive care drugs industry further. China and India are promising locations for the development of the cancer supportive care drugs industry. Factors such as increasing biosimilar uptake, effective healthcare reforms, and low-cost bases are providing a boost to the market in these two nations.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
The report presents a detailed analysis of the following key players in the global cancer supportive care drugs market, looking into their capacity, market shares, and latest developments like capacity expansions, plant turnarounds, and mergers and acquisitions:
The EMR report gives an in-depth insight into the industry by providing a SWOT analysis as well as an analysis of Porter’s five forces.
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!
In 2023, the global market for cancer supportive care reached a value of USD 21.18 billion.
The market is anticipated to grow at a CAGR of 2.3% during the forecast period of 2024-2032 to reach a value of USD 25.99 billion by 2032.
The major drivers of the industry, such as the rising demand for supportive care drugs, increased biosimilar uptake, increased expenditure on the healthcare sector, and the rising accessibility to efficient therapeutic techniques, are expected to aid the market growth.
The key market trend guiding the industry growth includes the development of the cancer supportive care drugs.
The major regions in the industry are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific.
The leading drug classes of the product in the industry are G-CSFs, erythropoietin stimulating agents (ESA), antiemetics, bisphosphonates, opioids, and NSAIDs, among others.
The major players in the industry are HELSINN Healthcare SA, F. Hoffmann-La Roche AG, Merck & Co., Inc., Amgen Inc., and Novartis International AG, among others.
Explore our key highlights of the report and gain a concise overview of key findings, trends, and actionable insights that will empower your strategic decisions.
| REPORT FEATURES | DETAILS |
| Base Year | 2023 |
| Historical Period | 2017-2023 |
| Forecast Period | 2024-2032 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Drug Type |
|
| Breakup by Cancer Type |
|
| Breakup by Distribution Channel |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Supplier Landscape |
|
| Companies Covered |
|
Purchase Full Report
Datasheet
Single User License
One User
Five User License
Five Users
Corporate License
Unlimited Users
How To Order
Our step-by-step guide will help you select, purchase, and access your reports swiftly, ensuring you get the information that drives your decisions, right when you need it.
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.
Australia
63 Fiona Drive, Tamworth, NSW
+61-448-061-727
India
C130 Sector 2 Noida, Uttar Pradesh 201301
+91-858-608-1494
Philippines
40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City,1226.
+63-287-899-028, +63-967-048-3306
United Kingdom
6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London
+44-753-713-2163
United States (Head Office)
30 North Gould Street, Sheridan, WY 82801
+1-415-325-5166
Vietnam
193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City
+84-865-399-124
United States (Head Office)
30 North Gould Street, Sheridan, WY 82801
+1-415-325-5166
Australia
63 Fiona Drive, Tamworth, NSW
+61-448-061-727
India
C130 Sector 2 Noida, Uttar Pradesh 201301
+91-858-608-1494
Philippines
40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City, 1226.
+63-287-899-028, +63-967-048-3306
United Kingdom
6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London
+44-753-713-2163
Vietnam
193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City
+84-865-399-124
Share